as of 12-05-2025 11:10am EST
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 16.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 43.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.78 - $5.00 | Next Earning Date: | 11-13-2025 |
| Revenue: | $113,037 | Revenue Growth: | 178.19% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
See how AIMD stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "AIMD Ainos Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.